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Abstract: The series of complexes [Os(bpy)3-n(pytz)n][PF6]2 (bpy = 2,2’-bipyridyl, pytz = 1-benzyl-4-(pyrid-2-
yl)-1,2,3-triazole, 1 n = 0, 2 n = 1, 3 n = 2, 4 n = 3) have been prepared and characterised and are rare examples 
of luminescent 1,2,3-triazole-based osmium(II) complexes. For 3 we present an attractive and particularly mild 
preparative route via an osmium(II) 6-arene precursor circumventing the harsh conditions that are usually 
required. Due to the high spin-orbit coupling constant associated with the Os(II) centre the absorption spectra of 
the complexes all display absorption bands of appreciable intensity in the range 500 – 700 nm corresponding to  
spin-forbidden ground-state-to-
3
MLCT transitions, which occur at significantly lower energies than the 
corresponding spin-allowed 
1
MLCT transitions. The homoleptic complex 4 is a bright emitter (max
em
 = 614 nm) 
with a relatively high quantum yield of emission of ~ 40 % in deoxygenated acetonitrile solutions at RT. Water 
soluble chloride salts of 1-4 were also prepared, all of which remain emissive in aerated aqueous solutions at 
room temperature. The complexes were investigated for their potential as phosphorescent cellular imaging agents 
whereby efficient excitation into the 
3
MLCT absorption bands at the red side of the visible range circumvents 
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autofluorescence from biological specimens which do not absorb in this region of the spectrum. Confocal 
microscopy reveals 4 to be readily taken up by cancer cell lines (HeLa and EJ) with apparent lysosomal and 
endosomal localisation, whilst toxicity assays reveal that the compounds have low dark and light toxicity. These 
complexes therefore provide an excellent platform for the development of efficient luminescent cellular imaging 
agents with advantageous photophysical properties which enable excitation and emission in the biologically 
transparent region of the optical spectrum. 
Introduction 
Over recent decades innumerable reports have appeared in the literature on kinetically inert complexes of d
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transition metals such as Re(I), Ru(II) and Ir(III) detailing their extensive photophysical properties.
1
 Of particular 
interest is the application of luminescent transition metal complexes as biocompatible probes for cellular 
imaging
2-7
 which have recently become of interest for such applications alongside previously explored complexes 
of some  p – and f-block elements.8, 9 With d6 complexes typically displaying long-lived triplet metal-to-ligand 
charge-transfer (
3
MLCT) excited states from which phosphorescence occurs, time-gated techniques enable 
selective imaging of the transition metal complex probe without interference from background cellular 
autofluorescence. 
 Osmium(II) complexes exhibit significantly advantageous photophysical properties for biological 
imaging applications
10-13
; the high spin-orbit coupling constant associated with the osmium centre results in the 
usually spin-forbidden direct ground state to 
3
MLCT state transitions to become of appreciable intensity in the 
UV-visible absorption spectra.
14, 15
 These transitions occur at wavelengths significantly red-shifted relative to the 
corresponding spin-allowed transitions populating 
1
MLCT states, and thus appear in the optimum window for the 
biologically transparent region. Emission from osmium(II)-based MLCT states typically occurs in the red to near-
IR regions of the spectrum. These absorption and emission properties thus enable greater depth of tissue 
penetration for excitation (which can additionally be achieved at lower excitation energies thereby limiting tissue 
damage) and imaging of emission. Further, the ability to excite these complexes directly to the 
3
MLCT state at 
longer wavelengths typically necessary for complexes of ruthenium(II), for example, aids the avoidance of 
autofluorescence from intrinsic biological chromophores, thus making imaging simpler and circumventing the 
need for time-gating techniques to achieve autofluorescence-free imaging. 
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 Whilst there have been many examples of phosphorescent probes based on complexes of rhenium(I), 
ruthenium(II) and iridium(III) there have been only a handful of reports concerning the use of osmium(II) 
complexes for cellular imaging applications.
16-19
 For example, Keyes and co-workers have reported a 
polyarginine-conjugated osmium(II) imidazophenanthroline complex for near-IR live-cell imaging applications.
20
  
Chao and co-workers recently reported a benzimidazolylpyridine-based osmium(II) complex which exhibited 
near-IR emission and lysosomal localisation upon cellular uptake.
21
  
Recent years have seen a large number of reports concerning luminescent complexes of rhenium(I) and 
iridium(III) bearing 1,2,3-triazole-derived ligands
22, 23
 with applications in light-emitting electrochemical cells 
and light-emitting diodes
24, 25
 and biological imaging.
26-30
 Osmium(II) complexes incorporating 1,2,3-triazole-
based ligands are, on the other hand, rather rare.
31
 There are only a few reported examples of luminescent 
dicationic osmium(II) complexes bearing neutral ligands incorporating a 5-membered heterocycle such as 1,2,4-
triazoles.
32, 33
 More commonly reported are charge-neutral complexes with anionic 1,2,4-triazolate or pyrazolate 
ligand systems which are frequently combined with phosphine, arsine or carbonyl donors.
34-38
 We have recently 
reported a series of tris-bidentate triazole-based osmium(II) complexes and their application in light-emitting 
electrochemical cell devices
39, 40
 and the bis-tridentate complex [Os(btzpy)2]
2+
 (btzpy = 2,6-bis(1-phenyl-1,2,3-
triazol-4-yl)pyridine) which exhibits phosphorescence at 595 nm. This latter complex was shown to be readily 
taken up by HeLa and U2OS cancer cell lines and displays a high degree of mitochondrial localisation.
41
 
The present work develops the area of Os(II) complexes with 1,2,3-triazole ligands and demonstrates the 
ability to systematically tune their photophysical properties. We present a systematic study on the coordination 
chemistry and photophysical properties of osmium(II) pytz complexes [Os(bpy)3-n(pytz)n]
2+ 
(1 n = 0, 2 n = 1, 3 n 
= 2, 4 n = 3) and their application in live cell imaging. The bpy-containing complexes are emissive in the deep-
red/near-IR whilst the homoleptic complex [Os(pytz)3]
2+
 is brightly emissive in the orange region of the 
spectrum. These attractive photophysical properties and our previous work led us to prepare water soluble 
chloride salts of these complexes and assess their potential in cellular imaging.   
 
Results and Discussion 
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The complex [Os(bpy)2(pytz)][PF6]2 (2) was prepared by adaptation of established procedures for the synthesis of 
heteroleptic osmium(II) complexes (Scheme 1).
39, 42
 Briefly, [Os(bpy)2Cl2] was heated under refluxing conditions 
in ethylene glycol with an equivalent of the pytz ligand. Subsequent counter-ion metathesis with ammonium 
hexafluorophosphate then enabled isolation of 2 as a dark green solid. As the pytz ligand is not symmetrical the 
two bpy ligands give rise to two separate sets of resonances in the 
1
H NMR spectrum of 2. The pyridyl triazole 
ligand exhibits a resonance for the triazole ring proton at  8.59, shifted downfield by 0.33 ppm relative to the 
corresponding resonance for the free ligand ( 8.26 in CD3CN). 
 
Scheme 1. Synthesis of [Os(bpy)2(pytz)][PF6]2 (2), cis,cis-, cis,trans- and trans,cis-[Os(bpy)(pytz)2]
2+
 (cis,cis-3, 
cis,trans-3 and trans,cis-3) and mer- and fac-[Os(pytz)3][PF6]2 (mer-4 and fac-4). 
 Crystals of X-ray diffraction quality were obtained for 2 and the molecular structure of the cation is 
depicted in Figure 1. The complex crystallises in the space group P21/n with a co-crystallised acetonitrile solvent 
molecule per osmium centre. The cation adopts a distorted octahedral geometry with unremarkable Os-N bond 
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lengths which vary from 2.02 to 2.09 Å. The bite angles of the three chelate ligands are very similar and are 
similarly unremarkable at approximately 78 .  
 
Figure 1. Molecular structure of the cation [Os(bpy)2(pytz)]
2+
 (ellipsoids at 50 % probability, hydrogen atoms, 
co-crystallised acetonitrile solvent molecule and hexafluorophosphate counterions removed for clarity). Selected 
bond lengths (Å) and angles (): Os(1)-N(1) 2.058(4), Os(1)-N(2) 2.062(4), Os(1)-N(3) 2.042(5), Os(1)-N(4) 
2.062(4), Os(1)-N(5) 2.024(4), Os(1)-N(8) 2.090(5), N(1)-Os(1)-N(2) 78.08(17), N(3)-Os(1)-N(4) 78.20(17), 
N(5)-Os(1)-N(8) 77.73(17), N(1)-Os(1)-N(4) 172.83(17), N(2)-Os(1)-N(5) 173.49(17), N(3)-Os(1)-N(8) 
172.76(16). (Crystallographic information file: CCDC 1826209) 
The complex [Os(bpy)(pytz)2][PF6]2 (3) was prepared through a two-step procedure (Scheme 1), making 
use of a bipyridine-containing intermediate [Os(6-C6H6)(bpy)Cl][PF6], itself formed from the reaction between 
bpy and the chloro-bridged dimer [{Os(6-C6H6)Cl2}2] as has been described elsewhere.
39
 The pytz ligands were 
coordinated through reaction with [Os(6-C6H6)(bpy)Cl][PF6] in refluxing EtOH/H2O, with the addition of 
NH4PF6 affording the final product as the hexafluorophosphate salt. As we have shown previously, as well as 
here, this osmium(II) arene route to heteroleptic complexes offers a significantly milder route as an alternative to 
the harsh conditions involving high boiling solvents normally associated with the synthesis of such materials. 
Due to the asymmetry of the pytz ligand, the complex is produced as a mixture of three isomers, cis,cis-3, 
cis,trans-3 and trans,cis-3 dependent on the respective regiochemistry of the pyridyl and triazole moieties of the 
two pytz ligands. Despite exhaustive efforts these isomers could not be satisfactorily separated by column or 
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preparative thin-layer chromatography. Subsequent results are therefore discussed based on analysis of 3 as a 
mixture of the three possible isomers. 
The homoleptic complex [Os(pytz)3][PF6]2 (4) was prepared by reaction of (NH4)2OsCl6 with three 
equivalents of pytz in ethylene glycol under refluxing conditions followed by counter-ion metathesis. Due to the 
asymmetry of the pytz ligand the 
1
H NMR spectrum of the initial product understandably shows signals for both 
meridional (mer-4) and facial (fac-4) isomers of 4 in an approximate 1:1.4 ratio (Figure 2). Separation of the two 
isomers proved extremely difficult, in contrast to the separation of the analogous ruthenium(II) system,
43
 with 
both co-eluting in column chromatography with a wide range of solvent systems. However, successful separation 
was possible on a small scale by preparative thin-layer chromatography yielding very small quantities of each 
isomer, sufficient to allow spectroscopic characterisation. 
 
Figure 2. 
1
H NMR spectra of 4 as a mixture of fac and mer isomers (top), mer-4 (middle) and fac-4 (bottom) in 
d3-acetonitrile. 
For mer-4, where the three pytz ligands are magnetically unique, three singlet resonances are observed at 
 8.59, 8.60 and 8.62 corresponding to the triazole ring protons (Figure 2). These are accompanied by resonances 
in the region  5.50-5.58 corresponding to the methylene protons of the benzyl substituents, one unique pair of 
which appears as a singlet at  5.50 displaying a strong nOe correlation signal with the proximal triazole ring 
proton at  8.60. Single crystals were grown for mer-4 and the structure obtained. Whilst there is some residual 
electron density near to the metal that could not be satisfactorily modelled the data clearly shows the meridional 
arrangement of the pyridine and triazole rings of the pytz ligands. The structure is provided in the Supporting 
Information for reference (Figure S21). 
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The 
1
H NMR spectrum of fac-4 is much simpler than that of its meridional isomer due to the C3 
symmetry of the cation (Figure 2). A singlet resonance is observed at  8.61 for the triazole ring proton along 
with a resonance at  5.50 for the benzylic methylene protons. These are accompanied by four discrete signals for 
the pyridine rings, the most downfield of which ( 8.07) is assigned to the H3 position owing to the nOe 
correlation with the triazole ring proton. The resonances for the H
4
, H
5
 and H
6
 positions give rise to signals 
centred at  7.82, 7.20 and 7.72 respectively as determined through COSY NMR analysis. The benzylic phenyl 
ring protons comprise the two remaining resonances at  7.14 and 7.31-7.40.  
 Complexes 1 and 2 together with the isomeric mixtures for complexes 3 and 4 were analysed by cyclic 
voltammetry (Figure 3) with electrochemical data summarised in Table 1. All complexes exhibit a reversible 
oxidation process centred between +0.44 and +0.46 V assigned to the Os(II)/Os(III) redox couple. The consistent 
oxidation potential across the series is indicative of a predominantly metal-centred HOMO. Complex 2 exhibits 
two reversible bpy-centred reductions at -1.71 and -1.94 V which are cathodically shifted relative to those 
observed for 1, consistent with a destabilisation of the LUMO upon exchange of a bpy ligand for pytz. Likewise, 
the first reduction process observed for 3 is assigned to a bpy-centred process, with the further cathodic shift to -
1.79 V again consistent with progressive destabilisation of the LUMO as more pytz ligands are included within 
the ligand set. An additional electrochemically quasi-reversible process is observed for 3 at -2.25 V, likely 
involving reduction of one of the pytz ligands. For 4, only one quasi-reversible ligand-centred reduction is 
observed within the available electrochemical window at -2.11 V. The notable cathodic shift in this reduction 
potential of 4 relative to 1-3 is indicative of a significantly higher energy LUMO resulting from the necessary 
localisation of this orbital upon pytz rather than bpy.   
Table 1. Electrochemical data for 1.5 mmol dm
-3
 MeCN solutions of complexes 1-4 measured at r.t. at a scan rate 
of 100 mVs
-1
. Potentials are shown in V vs. Fc
+
/Fc. Anodic-cathodic peak separations, ΔEa,c are shown in mV 
within brackets (ΔEa,c for Fc
+
/Fc  was typically 70 mV). 
Complex Eox / V Ered / V 
1 0.44 (77) -1.65 (67), -1.85 (76), -2.16 (76) 
2 0.44 (71) -1.71 (66), -1.94 (72) 
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3 0.45 (78) -1.79 (85), -2.25 (97) 
4 0.46 (72) -2.11 (79) 
 
 
Figure 3. Cyclic voltammograms for 1.5 mmol dm
-3
 MeCN solutions of complexes 1-4 recorded at r.t. at 100 
mVs
-1
. Solutions contained 0.2 mol dm
-3
 NBu4PF6 as supporting electrolyte. All potentials are shown against the 
Fc
+
/Fc couple. 
The photophysical data for complexes 1 to 4 are summarised in Table 2. The UV-visible electronic 
absorption spectra of 1-3 in acetonitrile (Figure 4) exhibit a sharp and intense band at ~290 nm ascribed to singlet 
ligand-centred * transitions localised on bpy. This band is seen to decrease in intensity as bpy ligands are 
sequentially replaced by pytz, being accompanied by the rise in a new feature discernible at ~275 nm attributed to 
similar * transitions centred on the pytz ligands. In the visible region the complexes exhibit panchromatic 
absorption with moderately intense absorption bands between 330 and 520 nm in addition to absorptions of lower 
intensity at longer wavelength tailing off towards 700 nm. The more intense bands between 420 and 500 nm for 1 
to 3 are assigned to spin-allowed 
1
MLCT transitions to bipyridyl ligand(s) whereas the weaker and lower energy 
bands are assigned to spin-forbidden direct 
3
MLCT transitions.
15
 It is noted that these 
1,3
MLCT bands for 2 and 3 
are progressively blue shifted and reduce in intensity relative to those of 1 as the bpy-centred LUMO is 
destabilised upon substitution of bpy ligands for pytz. An increase in extinction coefficient observed for 3 
between 330 and 420 nm is assigned to the contribution from 
1
MLCT {Os-to-pytz} transitions. The spectra of 
mer-4 and fac-4 similarly feature absorption bands in the visible region assigned to both spin-allowed {Os-to-
pytz} 
1
MLCT (~350 to 430 nm) and spin-forbidden 
3
MLCT transitions (~450 to 550 nm). However, since the 
LUMO of the pytz ligand is significantly destabilised relative to that of bpy these bands are significantly blue-
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shifted compared to the absorption profiles of 1-3. These data mirror the behaviour observed for related series of 
ruthenium(II) and osmium(II) triazole-containing complexes.
39, 44, 45
 
Table 2. Summarised photophysical data for 1-3, mer-4 and fac-4. 
Complex abs / nma  em / nma em / nmb  / nsa em / %a,d em / %c,d em / %b,d 1O2 /%
e 
1 651, 585, 485, 451, 
438, 390, 372, 331, 
290, 254, 246 
RT 732 g 736 38 0.5  0.8 0.3 26 
  77 K f 706, 778h       
2 639, 575, 473, 432, 
391, 363, 330, 289, 
280, 242 
RT 729 g 732 42 0.5   0.9 0.3 19 
  77 K f 698, 765 i       
3 590, 459, 388, 355, 
287, 275, 239 
RT 716 g 718 53 0.7   1.3 0.4 32 
  77 K f 683, 742 i       
mer-4 530, 485, 406, 380, 
315, 274, 238 
RT 613 h - 50 1.3  47 - - 
  77 K f 568, 611 i       
fac-4 523, 488, 404, 379, 
310, 274, 239 
RT 615 h - 50 1.2  40 - - 
  77 K f 576, 618i       
mer/fac-4    622 50 
340b 
(692 j) 
- - 2.9  
(6.2 j)  
62 
a Aerated MeCN. b chloride salt in aerated aqueous solution. c Deoxygenated MeCN. d Relative to [Ru(bpy)3][PF6]2. em = 0.018 in aerated MeCN. Ref 
46,                     
e chloride salt in aerated MeCN solution, relative to perinaphthenone. f In 4:1 EtOH/MeOH glass. g ex = 440 nm. 
h ex = 520 nm. 
i ex = 500 nm. 
j chloride 
salt in Argon equilibrated aqueous solution. 
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Figure 4. UV-visible electronic absorption spectra recorded for acetonitrile solutions of complexes 1-3, mer-4 
and fac-4 (inset: expansion of regions for
 1
MLCT and 
3
MLCT bands). 
Complex 2 exhibits phosphorescence in aerated acetonitrile with a broad, featureless band in the 
red/near-infrared region of the spectrum (max = 729 nm, Figure 5), attributed to an emissive state of 
3
MLCT 
character. The emission is slightly blue-shifted relative to that of [Os(bpy)3]
2+
 (max = 732 nm), with emission 
from 3 further shifted to higher energy (max = 716 nm). This progressive trend due to destabilisation of the 
LUMO of the complex after replacement of the bpy ligands by pytz is in agreement with both UV-visible 
absorption and electrochemical data. Due to the appreciable intensity of the spin-forbidden 
3
MLCT absorption 
bands excitation at wavelengths as long as 600 nm enable recording of emission spectra.  
Emission spectra were also recorded for the isomerically pure homoleptic complexes mer-4 and fac-4, 
with both showing near identical broad bands in the visible region (max ~ 614 nm). The dramatic shift of 
emission maxima to higher energy compared to 1-3 again mirrors the large blue-shift in their absorption profiles. 
Complexes 1 to 3 display short luminescence lifetimes (38 to 53 ns) and low emission quantum yields 
(0.5 to 0.7 %) in aerated acetonitrile solutions which obey the energy-gap law but are typical of dicationic bpy-
based osmium(II) complexes
47
 and those containing 1,2,4-triazole
32, 33
 and -triazolate ligands.
48
 The quantum 
yields increase to 0.8 to 1.3 % upon deoxygenating the solutions, in accordance with the triplet character of the 
emitting states. The homoleptic complexes mer-4 and fac-4 exhibit increased emission quantum yields relative to 
their bpy-containing heteroleptic analogues (1.2 – 1.3 %) which undergo dramatic enhancement on 
deoxygenating the solutions (47 and 40 % respectively). Approximate Stern-Volmer constants KSV where 
estimated for each complex using the relations I/I0 = 1 + KSV[O2] where I and I0 are the emission intensities at the 
given O2 concentration and in deaerated solutions respectively. The data show that only moderate quenching of 
emission is observed for the bpy-containing complexes with KSV < 10 atm
-1
. However, the homoleptic complex 4 
is found to exhibit far greater oxygen sensitivity with KSV values of 83 and 86 atm
-1
 for the meridional and facial 
isomers respectively. These observations are consistent with the measured photoluminescence quantum yields. 
Emission spectra recorded for 1-3, mer-4 and fac-4 at 77 K in EtOH / MeOH glass matrices (Figure 5, 
bottom) display vibronic structure, are shifted to higher energy relative to the corresponding solution state spectra 
11 
 
due to rigidochromic effects, and exhibit the same trend in emission energy with increasing pytz content across 
the series as the emission spectra recorded in fluid solutions. 
 
 
 
 
Figure 5. Top: Normalised emission spectra recorded for aerated MeCN solutions of 1-3, mer-4 and fac-4 at r.t. 
Bottom: Low temperature emission spectra (77 K) for complexes 1-3, mer-4 and fac-4 in a 4:1 EtOH:MeOH 
glass. 
In order to obtain a deeper understanding of the photophysical properties of the complexes, density 
functional theory (DFT) calculations have been performed. The geometries of the cations for all possible linkage 
isomers of the complexes were calculated. In each case the benzyl substituents were simplified to methyl to 
reduce computational expense, since this replacement will have little impact on the photophysical properties. 
Representative plots of the HOMO and LUMO frontier orbitals are depicted in Figure 6 whilst computed energies 
of these orbitals and the energy gap between them are provided in Table 3. In each case the HOMO is of Os dz
2
 
character whose energy is largely unaffected by the ligand set in agreement with the electrochemical data (vide 
supra). For the bpy-containing complexes 2 and 3 the LUMO is localised on the bpy ligands and is slightly 
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destabilised as the number of pytz ligands is increased. For 4 the LUMO is predominantly distributed over the 
pyridine rings of the three pytz ligands and is approximately 0.45 eV higher in energy compared to that of 2, 
indicative of the significantly destabilised LUMO localised on the pytz ligand compared to that on the bpy ligand. 
Time-dependent DFT (TDDFT) calculations were carried out in order to determine Frank-Condon 
excitation energies from the ground states to singlet excited states and thus simulate the optical absorption spectra 
of the complexes. Summarised data for selected transitions are provided in the Supporting Information. The 
energies of the more intense transitions in the calculated spectra align well with the experimental UV-visible 
absorption spectra for the complexes with a slight over-estimation of the energies. In all cases the S1 states are of 
predominantly HOMOLUMO 1MLCT character but are of low oscillator strength (f  0.005) and thus will 
contribute little to the experimentally observed absorption spectra. The first major transition for 2 occurs at 431 
nm (S5) and is of mixed HOMO-1LUMO+1 and HOMO-2LUMO 
1
MLCT character where the excess 
electron density resides on the bpy ligands. For cis,cis-3 and cis,trans-3 comparable transitions are blue-shifted 
relative to that of 2 (419 nm (S5) and 417 nm (S5) respectively) in line with the experimentally determined optical 
absorption spectrum. For trans,cis-3 a lesser blue-shift in the first intense transition (426 nm, S3) is observed. 
These calculations for 2 and 3 also reveal that several transitions occur at higher energy (370-400 nm) that have 
1
MLCT character with charge transfer to pytz. The lowest energy intense transitions for fac-4 and mer-4 appear at 
393 nm (S4) and 396 nm (S4) respectively. These were determined to be of predominantly HOMO-1LUMO 
and HOMO-2LUMO 1MLCT character respectively with localisation of the electron density in the excited 
state on the pytz ligands. The TDDFT data also confirmed assignments of the high energy intense bands below 
300 nm as having 
1
LC * character. 
13 
 
 
Figure 6. Representative plots of the HOMO and LUMO for 2, cis,cis-3 and fac-4. 
Table 3. Calculated energies of HOMO and LUMO orbitals (eV) of complexes 1 to 4 and associated HOMO-
LUMO gap. 
Complex HOMO LUMO HOMO - LUMO 
2 -6.20 -2.67 3.53 
cis,cis-3 -6.18 -2.57 3.61 
cis,trans-3 -6.18 -2.53 3.65 
trans,cis-3 -6.19 -2.60 3.58 
mer-4 -6.17 -2.22 3.95 
fac-4 -6.17 -2.21 3.96 
 
Complexes 1-3, mer-4 and fac-4 as their PF6
-
 salts were subject to counter ion metathesis to yield the 
corresponding water soluble chloride salts. UV-visible absorption spectra recorded in water (Figure 7) closely 
resemble those of the corresponding hexafluorophosphate salts dissolved in acetonitrile (Figure 4, Table 2). The 
14 
 
chloride salts of the complexes remain emissive in aqueous solution, as can be seen from the spectra displayed in 
Figure 7 (bottom). The bpy-containing complexes show broad unstructured bands with slightly lower but 
comparable quantum yields to those of the hexafluorophosphate salts in acetonitrile. These bands are, however, 
slightly solvatochromically red-shifted with respect to the PF6
- 
complexes in acetonitrile, consistent with the 
stabilisation of the emissive 
3
MLCT states due to the greater polarity of the solvent. The quantum yields of 
singlet oxygen sensitised by the chloride salts of 1 to 4 in acetonitrile solutions were determined (Table 2). 
Modest quantum yields of between 19 and 32 % are observed for the bpy-containing complexes with a higher 
quantum yield of 62 % observed for 4 in agreement with the quenching data for the hexafluorophosphate salts.  
 
 
Figure 7. Top: UV-visible electronic absorption spectra recorded for complexes 1 to 4 as their chloride salts in 
aqueous solution. Bottom: Emission spectra for 1-4 in aerated aqueous solution at r.t. (for 1 to 3 ex = 600 nm, for 
4 ex = 500 nm). 
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Figure 8. Dark viability MTT assay results for complexes 1 to 4 in EJ (bladder cancer) and HeLa (cervical 
cancer) cell lines following a 6 hour incubation with a 50 µM solution of the relevant complex. 
 
Due to advantageous photophysical properties of the new Os(II) complexes as outlined above, we 
explored the potential of the complexes of these prototypical designs in preliminary confocal imaging studies. 
The cellular uptake, subcellular localisation and photo-induced cytotoxicity of complexes 1 to 4 as their water-
soluble chloride salts were investigated in the EJ bladder cancer cell line and the HeLa cervical cancer cell line. 
Figure 8 shows dark toxicity as measured by MTT viability assay for 1 – 4. To mimic imaging conditions, 
viability at 50 µM was measured immediately following a 6-hour incubation with each complex. In addition, to 
establish potential for therapeutic use, long-term viability was measured ~5 days after a 6 hour exposure to a 
higher dose of 100 µM (see Supporting Information Figure S19). These results indicate that the complexes have 
relatively low dark toxicity in both cell lines.  
Confocal microscopy studies demonstrate that 4 enters cells, with only moderate cellular uptake of 3 
being observed. Based on the lack of luminescence observed in the confocal microscopy experiments we 
conclude that 1 and 2 do not enter cells even following a 24 hour incubation (see Supporting Information Figure 
S18). Confocal images of 4 (20 μM) following a 6 hour incubation in the EJ bladder carcinoma cell line are 
presented in Figure 9. Localisation studies were hampered due to overlap of the absorption and emission bands of 
the probe with those of co-localisation stains and as such Pearson coefficients could not be reliably calculated. 
However, the emission shows cytoplasmic localisation with a distinct punctate pattern, which given the cationic 
16 
 
nature of the complexes is likely to be due to lysosomal and/or endosomal localisation. Similar localisation for 3 
was observed (see Supporting Information Figure S18). 
Whilst the complexes exhibit low dark toxicity (dark LD50 > 100 M, Figure S19) the high degree of 
oxygen-based luminescence quenching and high singlet oxygen quantum yield for 4 raise the possibility for 
significant photocytotoxicity which would be a disadvantage for application in live-cell imaging. We therefore 
carried out preliminary experiments to assess any potential photocytotoxicity. Pleasingly, and somewhat 
unexpectedly, the utilisation of 3.6 J cm
-2
 455 nm irradiation after incubation of cells with 3 and 4 (10 M) 
demonstrated no photo-activated cytotoxicity (see supporting information Figure S20). Currently it is not clear 
why this lack of photo-induced toxicity is seen. One may tentatively speculate that the lack of photosensitising 
activity at relatively low doses (10 μM) may be indicative of intrinsically lower singlet oxygen generation in 
cytoplasmic media or that the generation of singlet oxygen at the site of localisation is far less damaging than 
when generated at, for example, the mitochondria or nucleus.
49
 It could also be tentatively suggested that the 
observed localisation results in envelopment of the complex in lysosomal structures, thus shielding the complex 
from molecular oxygen and resulting in reduced quenching and efficient luminescent staining. Nevertheless, the 
complexes presented here therefore provide an excellent platform for the further development of luminescent 
cellular imaging agents.  
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Figure 9. Confocal microscopy images of EJ bladder carcinoma cells incubated with complex 4 (20 μM, 6 
hour incubation). Each panel comprises emission image (left, λexc = 543 nm, λem = 565-615 nm),  bright-field 
image (right) and overlay of emission and bright-field images (centre). Scale bars = 20 μm. 
 
Conclusions 
The unique photophysical properties of osmium(II) complexes offer significant opportunities for biological 
imaging applications. The pyridyltriazole complexes reported here exhibit phosphorescence in the 
biologically transparent orange/red to deep red/near-IR region of the spectrum in aqueous solution (Cl-salts) 
or in acetonitrile solution (PF6-salts) through low energy excitation into spin-forbidden direct 
3
MLCT bands. 
The homoleptic tris(pyridyltriazole) complex 4 has been shown to be brightly emissive and undergoes 
cellular uptake in two cancer cell lines with likely lysosomal and endosomal localisation. Further 
development of this prototypical complex through variation of the structure of the triazole-based ligand 
could be envisaged to increase cellular uptake and to red-shift the absorption profile toward those of the 
heteroleptic complexes reported and thus provide an increased overlap with the optimum biological window. 
Modification of the bipyridyl substituents in the heteroleptic complexes may similarly result in improved 
cellular uptake for imaging in the deep-red region of the spectrum. The triazole complexes therefore present 
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an excellent platform for the development of non-toxic live-cell imaging probes which can be excited, and 
monitored, in the red region of the spectrum in the range of relative transparency of biological specimens. 
 
Experimental Section 
General Methods 
[Os(bpy)3][PF6]2,
42 
[Os(bpy)2Cl2],
42
, [{Os(6-C6H6)Cl2}2]
50
 [Os(6-C6H6)(bpy)Cl][PF6]
39
 and pytz
51
 were 
prepared according to previously reported procedures. Ammonium hexachloroosmate(IV) was purchased 
from Alfa Aesar whilst all other reagents were purchased from Sigma-Aldrich, Acros Organics or 
Fluorochem and used as supplied. All synthetic manipulations were carried out under an atmosphere of dry 
N2 employing standard Schlenk line techniques. Preparative thin layer chromatography was performed on 
silica plates (Analtech Uniplate) of size 20 x 20 cm and 1500 micron thickness. NMR spectra were recorded 
on Bruker Ascend 400 MHz and 500 MHz spectrometers, with all chemical shifts being quoted in ppm 
referenced relative to the residual solvent signal (MeCN, 
1
H:  1.94, 13C:  1.32, 118.26). High resolution 
mass spectrometry was performed on an Agilent 6210 TOF instrument with a dual ESI source. UV-visible 
absorption spectra were recorded on an Agilent Cary 60 spectrophotometer whilst emission spectra were 
recorded on a Fluoromax 4 spectrophotometer. Lifetime measurements were recorded by time-correlated 
single-photon counting using an Edinburgh Instruments Mini-Tau spectrometer. Cyclic voltammograms 
were measured using a PalmSens EmStat3 potentiostat with PSTrace electrochemical software (version 4.8). 
Analyte solutions (typical concentration 1.5 mmol dm
-3
) were prepared using nitrogen saturated dry 
acetonitrile, freshly distilled from CaH2. All measurements were conducted at room temperature under a 
stream of dry nitrogen at potential scan rates ranging from 50 to 500 mV s
-1
. NBu4PF6 was used as a 
supporting electrolyte, being recrystallised from ethanol and oven dried prior to use, with a typical solution 
concentration of 0.2 mol dm
-3
. The working electrode was glassy carbon, with platinum wire utilised as the 
counter electrode. The reference electrode was Ag/AgCl, being chemically isolated from the analyte solution 
by an electrolyte containing bridge tube tipped with a porous frit. Ferrocene was employed as an internal 
reference, with all potentials quoted relative to the Fc
+
/Fc couple. 
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Synthesis of [Os(bpy)2(pytz)][PF6]2 (2). 
[Os(bpy)2Cl2] (187 mg, 0.33 mmol) and pytz (80 mg, 0.34 mmol) were dissolved in ethylene glycol (10 ml) 
and refluxed under N2 for 4 hrs. The resulting solution was allowed to cool to room temperature, treated with 
excess NH4PF6 (262 mg, 1.60 mmol) and stirred for a further hour. H2O was added (10 ml) and the dark 
green precipitate collected by vacuum filtration and washed with cold water followed by diethyl ether. 
Purification was achieved via column chromatography (SiO2, 4:1 CH2Cl2 / MeCN) with collection of the 
dark green coloured band and evaporation of the solvent. The resulting residue was subsequently re-
dissolved in a small volume of 2 % MeOH / CH2Cl2 and passed through a short pad of alumina. Addition of 
excess hexane to the filtrate afforded the pure product as a dark green powder which was collected by 
filtration, washed with Et2O and dried in vacuo. Yield = 100 mg, 30 %. 
1
H NMR (CD3CN, 400 MHz,): 5.47 
(d, J = 15.0 Hz, 1H), 5.51 (d, J = 15.0 Hz, 1H), 7.11-7.27 (m, 4H), 7.28-7.43 (m, 6H), 7.52 (d, J = 5.6 Hz, 
1H), 7.67 (d, J = 5.6 Hz, 1H), 7.72 (d, J = 5.5 Hz, 1H), 7.74-7.91 (m, 7H), 8.07 (d, J = 7.9 Hz, 1H), 8.37-
8.46 (m, 2H), 8.49 (d, J = 8.2 Hz, 2H), 8.59 (s, 1H). 
13
C NMR (101 MHz, CD3CN): 56.47, 123.56, 124.61, 
124.98, 125.38, 125.45, 127.15, 127.31, 128.18, 128.86, 128.91, 129.04, 129.18, 130.01, 130.10, 134.58, 
137.91, 137.94, 137.96, 138.04, 138.60, 150.23, 151.87, 151.93, 152.24, 152.32, 152.43, 153.43, 159.96, 
160.30, 160.36, 160.77. HRMS (ES); m/z calc. for [OsC34H28N8]
2+
: 370.1020, found: 370.1027. Anal. Calc. 
for C34H28N8P2F12Os (%): C 39.69, H 2.74, N 10.89, found (%): C 39.33, H 2.62, N 10.77. 
Synthesis of cis,cis-, cis,trans-, trans,cis-[Os(bpy)(pytz)2][PF6]2 (cis,cis-3, cis,trans-3, trans,cis-3). 
[Os(6-C6H6)(bpy)Cl][PF6] (149 mg, 0.25 mmol), pytz (124 mg, 0.53 mmol) and NaPF6 (100 mg, 0.59 
mmol) were added to deaerated 3:1 (v/v) EtOH/H2O (25 ml) and heated to 90 
o
C under an N2 atmosphere for 
48 hrs. The solution was allowed to cool to room temperature with the resulting precipitate collected by 
filtration and washed with H2O followed by Et2O. Purification was achieved via column chromatography 
(SiO2, 2% MeOH / CH2Cl2), with the product eluting from a dark brown coloured band. Evaporation of the 
solvent to a minimum and addition of hexane precipitated the title complex as a brown coloured powder. 
Yield = 99 mg, 36 %. The product was obtained as a mixture of the cis,cis-; cis,trans-; and trans,cis- isomers 
which were not separated. 
1
H NMR (CD3CN, 400 MHz): 5.44-5.58 (m, 4H), 7.08-7.14 (m, 1H), 7.15-7.43 
(m, 13 H), 7.59-7.67 (m, 2H), 7.73-7.90 (m, 6H), 8.03-8.11 (m, 2H), 8.35-8.46 (m, 2H), 8.56-8.63 (m, 2H). 
13
C NMR (CD3CN, 126 MHz): 56.36, 56.57, 123.19, 123.50, 123.56, 124.35, 124.56, 125.01, 126.45, 
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127.16, 127.18, 127.34, 128.04, 128.07, 128.79, 128.82, 129.20, 129.31, 129.93, 130.02, 130.05, 130.10, 
130.12, 134.56, 134.73, 134.99, 137.77, 137.83, 137.95, 138.41, 138.44, 138.50, 150.20, 150.70, 150.95, 
151.98, 152.24, 152.34, 152.41, 152.56, 153.03, 153.59, 153.83, 153.85, 160.76, 160.79, 160.97. HRMS 
(ES); m/z calc. for [OsC38H32N10]
2+
: 410.1208, found: 410.1209. Anal. Calc. for C38H32N10P2F12Os (%): 
Satisfactory elemental analysis could not be obtained for this compound. 
Synthesis of mer- and fac-[Os(pytz)3][PF6]2 (mer-4 and fac-4). 
[OsCl6][NH4]2 (202 mg, 0.46 mmol) and pytz (412 mg, 1.74 mmol) were dissolved in ethylene glycol (15 
ml) and refluxed under N2 for 2 hrs. The resulting solution was allowed to cool to room temperature, excess 
NH4PF6 (324 mg, 1.98 mmol) added and the mixture then stirred for a further 30 mins. H2O (15 ml) was 
added and the dark orange precipitate then isolated by vacuum filtration, being washed with cold water 
followed by Et2O. Purification was performed via column chromatography (SiO2, 2% MeOH / CH2Cl2), with 
the product eluting from a bright red coloured band. Evaporation of the solvent to a minimum volume and 
addition of excess hexane precipitated the product as a red/orange coloured solid. Yield = 411 mg, 75 %. The 
product was found to be composed of a mixture of the meridonal and facial isomers in approximately a 1:1.4 
respective ratio as estimated by 
1
H NMR. Separation of these isomers was achieved through preparative thin 
layer chromatography (SiO2, gradient elution, CH2Cl2 then 1:4 acetone/CH2Cl2) with the first orange 
coloured band containing exclusively the meridonal isomer. The facial isomer was obtained from the second 
(lower Rf ) coloured band.  
mer-[Os(pytz)3][PF6]2: 
1
H NMR (CD3CN, 400 MHz): 5.50 (s, 2H), 5.52-5.58 (m, 4H), 7.12-7.19 (m, 4H), 
7.20-7.27 (m, 5H), 7.32-7.44 (m, 9H), 7.65-7.69 (m, 2H), 7.70-7.84 (m, 4H), 7.99-8.04 (m, 2H), 8.08 (d, J = 
7.9 Hz, 1H), 8.59 (s, 1H), 8.60 (s, 1H), 8.62 (s, 1H). 
13
C NMR (CD3CN, 126 MHz): 56.35, 56.58, 56.62, 
122.58, 122.74, 123.46, 126.19, 126.40, 126.82, 127.13, 127.22, 128.88, 129.32, 129.34, 129.95, 130.07, 
130.11, 130.13, 130.15, 134.61, 134.66, 135.00, 138.20, 138.27, 150.63, 151.01, 151.05, 152.56, 152.62, 
153.08, 153.98, 154.23, 154.41.  
fac-[Os(pytz)3][PF6]2: 
1
H NMR (CD3CN, 400 MHz): 5.50 (s, 6 H), 7.14 (dd, J = 1.8, 7.6 Hz, 6H), 7.20 (ddd, 
J = 1.3, 5.9, 7.8 Hz, 3H), 7.31-7.40 (m, 9H), 7.72 (d, J = 5.6 Hz, 3H), 7.82 (td, J = 1.3, 7.8 Hz, 3H), 8.07 (d, 
J = 7.9 Hz, 3H), 8.61 (s, 3H). 
13
C NMR (CD3CN, 126 MHz): 56.42, 123.20, 126.49, 127.08, 128.88, 129.95, 
130.12, 135.07, 138.42, 150.83, 152.46, 154.24. 
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HRMS (ES); m/z calc. for mer/fac-[OsC42H36N12]
2+
: 450.1395, found: 450.1406. Anal. Calc. for 
C42H36N12P2F12Os (%): C 42.43, H 3.05, N 14.14, found (%): C 42.21, H 2.97, N 13.97. 
 
General procedure for the preparation of water soluble chloride salts. 
The relevant Os complex as its hexafluorophosphate salt (100 mg) together with 2.5 weight equivalents of 
Amberlite chloride-form ion exchange resin (250 mg) were stirred in MeOH (25 ml) at room temperature in 
the dark for 24 h. The resin was removed by filtration and the filtrate evaporated to dryness. The residue was 
re-dissolved in the minimum volume of H2O (< 10 ml) with subsequent freeze drying affording the relevant 
chloride salts as powders. Successful counter-ion metathesis was confirmed by the complete absence of 
resonances in 
31
P and 
19
F NMR spectra. (
1
H NMR spectra for 1-4 as their chloride salts are presented within 
the ESI). 
 
Computational Methods.  
DFT calculations were carried out using the Gaussian 09 (Revision D.01) software package.
52
 The 
complexes were optimised using the PBE0 functional
53
 with the SDD effective core potential for osmium
54
 
and 6-311G* basis sets
55
 for all other atoms. Solvation was modelled using the PCM solvent model for 
acetonitrile as implemented in Gaussian 09. The benzyl substituents of the experimentally investigated 
complexes were replaced by methyl for simplicity in the calculations. Minima were confirmed through 
vibrational frequency analysis. In some cases negative frequency modes were observed and corresponded to 
rotation of the methyl groups. Vertical excitation energies were determined through TDDFT calculations for 
the lowest energy 30 singlet roots to yield simulated optical absorption spectra. 
Cell culture 
Both cell lines HeLa (human cervical cancer) and EJ (human bladder carcinoma) were purchased from 
American Type Culture Collection–LGC partnership (Teddington, UK) and used within 20 passages of 
purchase. Cells were cultured using Dulbecco’s modified Eagles Medium (DMEM) (Lonza, Cambridge UK) 
with 10% fetal calf serum (FCS) (Lonza, Cambridge UK) and cultured in an incubator (37 

C, 5 % CO2). The 
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cells were passaged when 70 – 80% confluency was reached and regularly checked for mycoplasma 
contamination. 
Stock solutions of 1 – 4 were stored in deionised water at 10 mM, aliquoted in small volumes to avoid 
freeze/thaw cycles 
Imaging 
EJ cells were seeded on cover slips (22 x 22 mm, sterilised in industrial methylated spirits) placed in 6 well 
dishes at a density of ~2 x 10
5
 per well and incubated overnight. Staining solutions of the desired compound 
were made by dilution into culture media and added to the cells for the desired time. Once incubation with 
the compounds had taken place the cells were washed (PBS x 3) and fixed (4% paraformaldehyde solution in 
PBS, 4 

C, 20 mins) before being washed again (PBS x 3) and mounted (IMMU-MOUNT, Life Technologies 
Ltd, Paisley, UK). 
The slides were imaged by confocal microscopy (Inverted Zeiss LSM 510 NLO microscope) using a 60 x 
lens with activation by helium-neon laser ( = 543 nm). Emission was registered in the region 565-615 nm or 
650-710 nm as specified. 
Singlet oxygen yield measurement 
The singlet oxygen yields  (1O2) of 1 – 4 were measured in air-equilibrated acetonitrile against the standard 
perinapthenone. The yields were determined by direct measurement of 
1
O2 phosphorescence in the NIR (em 
1275 nm) with irradiation of the compounds at 355 nm by a pulsed Nd:YAG laser as described previously.
56
  
MTT cell viability assay 
Cells were seeded in 96-well plates (1 x 10
4
 cells/well for short term and 1 x 10
3
 cells/well for long term 
survival assays) and incubated overnight to adhere. 1 – 4 were added to the cells for 6 hours. Immediately 
(short term assay) or after ~5 days growth in fresh media (long term assay) thiazoyl blue (MTT) solution was 
added to each well (25 μL, 3 mg cm−3 in PBS). After a 3 hour incubation the media and MTT solution was 
removed from each well and DMSO was added (250 μL/well) and crystals dissolved. Optical density of 
wells at 540 nm was recorded on a plate reader (Multiskan fc, Thermo Fisher Scientific, Warrington, UK). 
PDT 
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Cells were seeded in 6-well plates (2 x 10
4
 cells/well) and allowed to adhere by incubation overnight. 4 was 
added to the cells for 6 hours. Following treatment, cells were washed (PBS) and trypsinized then re-
suspended in PBS (2 ml) before each solution was divided. One half of each treatment concentration was 
kept in the dark while the other was treated with light (455 nm, 20 mW cm
-2
, 3 mins, 3.6 J cm
-2
) before cells 
were seeded at low density in 10 mm petri dishes (500 and 1000 cells/ dish) and left to form colonies (~10 
days). Once colonies had formed the plates were washed (PBS) and stained (4 % methylene blue in 70 % 
methanol solution). Each colony is considered to represent a surviving cell with survival fractions calculated 
as number of surviving treated cells/ control cells. 
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